STOCK TITAN

Shineco Stock Price, News & Analysis

SISI NASDAQ

Company Description

Company Overview

Shineco Inc (SISI) is a technologically advanced healthcare and biotechnology company committed to enhancing the quality of life by delivering safe, high-quality health products and services. With a diversified portfolio that spans in vitro diagnostic reagents, medical devices, and nutritionally enhanced food products, Shineco leverages advanced scientific research and innovative technologies to address critical challenges in healthcare. The company integrates state-of-the-art research with practical solutions that cater to medical institutions, pharmaceutical companies, and consumers seeking improved health outcomes.

Core Business Areas

Shineco operates across multiple segments that underline its comprehensive approach to healthcare:

  • Healthcare Diagnostics and Medical Devices: The company has developed a range of vitro diagnostic reagents and related medical devices that support accurate disease detection. These products are designed using precise scientific methods, ensuring they meet the rigorous demands of modern clinical environments.
  • Nutraceuticals and Functional Foods: Recognizing the critical need for balanced nutrition, Shineco produces and sells healthy and nutritious foods that serve as both traditional food sources and functional nutritional supplements. This dual focus helps consumers bridge the gap between daily food intake and specialized dietary needs.
  • Advanced Biotechnological Innovation: Shineco has recently demonstrated remarkable innovation in its proprietary extraction technology. By utilizing a pure physical extraction process, notably through large column chromatography and polar ultrafiltration membranes, the company is able to produce natural water-soluble phospholipids. These phospholipids retain their inherent biological structure and activity, setting a new benchmark in the extraction and utilization of critical cellular nutrients.

Innovative Extraction Technology

The cornerstone of Shineco’s technological edge is its breakthrough in extracting natural active phospholipids. Traditional methods relying on chemical solvents often disrupt the natural structure and functionality of these vital molecules. In contrast, Shineco’s method employs controlled temperature processes and an aqueous environment to preserve active functional groups. This innovative approach not only enhances the purity and effectiveness of the phospholipids but also lowers processing costs by increasing extraction efficiency. The technology holds promise for multiple applications in pharmaceuticals, functional foods, and even beauty and skincare products by providing a more natural alternative to chemically modified compounds.

Market Position and Competitive Landscape

Within an industry driven by continuous innovation and rigorous quality standards, Shineco has carved out a niche through its commitment to advanced, science-based product development. By focusing on retaining the natural state of biological molecules, the company differentiates itself from competitors that rely on more traditional, chemical-based extraction methods. Its diverse portfolio and innovative technology have established Shineco as a major player in healthcare diagnostics, nutraceuticals, and biotechnological research. This competitive differentiation is reinforced by a deep understanding of cellular nutrition and pharmacological integrity, lending credibility and trustworthiness from the standpoint of medical expertise and research acumen.

Operational Excellence and Quality Assurance

At its core, Shineco’s operational strategy is built on rigorous quality control measures and an unwavering commitment to research and development. The company emphasizes stringent protocols that ensure every product—from diagnostic reagents to functional food ingredients—meets high standards of safety and efficacy. This diligence in quality assurance demonstrates Shineco’s authority and expertise in the healthcare sector, fostering trust among consumers, healthcare professionals, and regulatory bodies alike.

Expertise in Biotechnology and Healthcare Innovation

Shineco’s commitment to innovation is evident in its investment in research that bridges the gap between cutting-edge science and practical health solutions. The company continuously challenges conventional methods by developing technologies that maintain the integrity of bioactive compounds. The expertise in biotechnology is not limited to product development; it also informs the company’s comprehensive approach to market challenges, regulatory requirements, and industry standards. By aligning scientific research with healthcare needs, Shineco provides a solid foundation for understanding complex cellular mechanisms and translating these insights into innovative therapies and treatments.

Conclusion

In summary, Shineco Inc (SISI) stands out as a multifaceted healthcare company that combines advanced diagnostics, nutritional science, and groundbreaking extraction technology to improve human health. Its comprehensive product portfolio, underpinned by robust scientific research and innovative technologies, positions the company as an authority in the healthcare industry. With a clear focus on maintaining natural product efficacy and operational excellence, Shineco continues to address crucial challenges in medical diagnostics and nutritional supplementation, offering a compelling narrative for investors and industry watchers seeking reliable and expert insights into the company’s operations.

Stock Performance

$—
0.00%
0.00
Last updated:
-84.23 %
Performance 1 year
$9.9M
Market Cap
17.2M
Shares outstanding

SEC Filings

No SEC filings available for Shineco.

Financial Highlights

$291,841
Revenue (TTM)
-$2,558,128
Net Income (TTM)
-$2.34
Diluted EPS (TTM)
-$2,085,232
Operating Cash Flow
-876.55%
Net Profit Margin
-819.07%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Shineco (SISI)?

The current stock price of Shineco (SISI) is $0.66 as of April 25, 2025.

What is the market cap of Shineco (SISI)?

The market cap of Shineco (SISI) is approximately 9.9M.

What is the revenue (TTM) of Shineco (SISI) stock?

The trailing twelve months (TTM) revenue of Shineco (SISI) is $291,841.

What is the net income of Shineco (SISI)?

The trailing twelve months (TTM) net income of Shineco (SISI) is -$2,558,128.

What is the earnings per share (EPS) of Shineco (SISI)?

The diluted earnings per share (EPS) of Shineco (SISI) is -$2.34 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Shineco (SISI)?

The operating cash flow of Shineco (SISI) is -$2,085,232.

What is the profit margin of Shineco (SISI)?

The net profit margin of Shineco (SISI) is -876.55%.

What is the operating margin of Shineco (SISI)?

The operating profit margin of Shineco (SISI) is -819.07%.

What is the gross margin of Shineco (SISI)?

The gross profit margin of Shineco (SISI) is 100.00%.

What is the current ratio of Shineco (SISI)?

The current ratio of Shineco (SISI) is 0.81, indicating the company's ability to pay short-term obligations.

What is the gross profit of Shineco (SISI)?

The gross profit of Shineco (SISI) is $291,841 on a trailing twelve months (TTM) basis.

What is the operating income of Shineco (SISI)?

The operating income of Shineco (SISI) is -$2,390,393.

What is the core business of Shineco Inc?

Shineco Inc focuses on healthcare diagnostics, development of medical devices, and nutraceuticals. It integrates advanced biotechnology with innovative extraction methods to enhance product quality.

How does Shineco innovate in the extraction of phospholipids?

The company utilizes a pure physical extraction method using large column chromatography and polar ultrafiltration membranes. This technique preserves the natural structure and activity of phospholipids, setting it apart from traditional chemical solvent methods.

What markets does Shineco serve?

Shineco serves multiple segments including healthcare diagnostics, functional foods, and the nutraceutical market. Its products are designed for medical institutions, pharmaceutical companies, and health-conscious consumers.

How does Shineco ensure product quality?

Quality assurance is maintained through rigorous quality control protocols and continuous research and development. The company adheres to high standards to ensure that its diagnostic reagents, medical devices, and food products are both safe and effective.

How does Shineco differentiate itself from competitors?

Shineco differentiates itself through its innovative physical extraction technique, which preserves the natural bioactivity of phospholipids. This advanced technology, combined with a diversified product portfolio, positions the company uniquely in the competitive healthcare landscape.

In what areas does Shineco apply its technological expertise?

Shineco applies its technological expertise in developing advanced diagnostic reagents, high-quality medical devices, and nutritious functional foods. Its innovations in phospholipid extraction also contribute to advancements in pharmaceutical, beauty, and cellular nutrition applications.